Total Payments
$679.50
2024 Payments
$115.51
Companies
17
Transactions
39
Medicare Patients
500
Medicare Billing
$85,909
Payment Breakdown by Category
Food & Beverage$679.50 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $679.50 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $86.49 | 2 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $84.69 | 2 | $0 (2018) |
| Lundbeck LLC | $59.36 | 4 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $56.82 | 4 | $0 (2021) |
| ABBVIE INC. | $53.23 | 3 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $49.93 | 4 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $40.23 | 2 | $0 (2024) |
| Indivior Inc. | $36.29 | 2 | $0 (2024) |
| Neuronetics, Inc. | $34.64 | 5 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $32.95 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.51 | 7 | Indivior Inc. ($36.29) |
| 2023 | $55.58 | 3 | Teva Pharmaceuticals USA, Inc. ($26.74) |
| 2022 | $45.97 | 3 | Vanda Pharmaceuticals Inc. ($17.52) |
| 2021 | $119.51 | 8 | AbbVie Inc. ($24.05) |
| 2019 | $145.33 | 5 | JAZZ PHARMACEUTICALS INC. ($71.71) |
| 2018 | $113.19 | 8 | ACADIA Pharmaceuticals Inc ($56.25) |
| 2017 | $84.41 | 5 | ACADIA Pharmaceuticals Inc ($28.44) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.91 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: OUD | ||||||
| 09/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: PSYCHIATRY | ||||||
| 03/29/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: OUD | ||||||
| 11/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Central Nervous System | ||||||
| 02/21/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.81 | General |
| Category: PSYCHIATRY | ||||||
| 05/24/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/26/2022 | Almatica Pharma LLC | GRALISE (Drug), SERTRALINE HCL, LOREEV XR | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 03/22/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2021 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: NEUROLOGY | ||||||
| 11/16/2021 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/09/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2021 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.35 | General |
| Category: PSYCHIATRY | ||||||
| 09/29/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, SPRAVATO | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Neuroscience | ||||||
| 05/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: NEUROLOGY | ||||||
| 02/25/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 09/10/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Schizophrenia | ||||||
| 08/15/2019 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $71.71 | General |
| Category: HEMATOLOGY | ||||||
| 04/24/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 69 | 197 | $50,987 | $14,294 |
| 2022 | 1 | 73 | 218 | $57,966 | $15,673 |
| 2021 | 5 | 161 | 342 | $102,929 | $27,313 |
| 2020 | 5 | 197 | 409 | $118,415 | $28,629 |
Total Patients
500
Total Services
1,166
Medicare Billing
$85,909
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 197 | $50,987 | $14,294 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 218 | $57,966 | $15,673 | 27.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 234 | $62,122 | $17,874 | 28.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 20 | $13,407 | $3,146 | 23.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 36 | 53 | $12,839 | $2,992 | 23.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 23 | 23 | $10,565 | $2,439 | 23.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 12 | 12 | $3,996 | $862.40 | 21.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 256 | $68,467 | $16,343 | 23.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 31 | 54 | $17,843 | $4,216 | 23.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 32 | 34 | $14,494 | $3,617 | 25.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 31 | 31 | $9,803 | $2,499 | 25.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 28 | 34 | $7,808 | $1,953 | 25.0% |
About Dr. Paul Richardson, MD
Dr. Paul Richardson, MD is a Psychiatry healthcare provider based in Saint Paul, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750369088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Richardson, MD has received a total of $679.50 in payments from pharmaceutical and medical device companies, with $115.51 received in 2024. These payments were reported across 39 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($679.50).
As a Medicare-enrolled provider, Richardson has provided services to 500 Medicare beneficiaries, totaling 1,166 services with total Medicare billing of $85,909. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Saint Paul, MN
- Active Since 01/06/2006
- Last Updated 11/24/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1750369088
Products in Payments
- NUPLAZID (Drug) $84.69
- VRAYLAR (Drug) $75.38
- DEFITELIO (Drug) $71.71
- REXULTI (Drug) $59.36
- INGREZZA (Drug) $56.82
- LATUDA (Drug) $49.93
- SUBLOCADE (Drug) $36.29
- NEUROSTAR TMS THERAPY (Device) $34.64
- CAPLYTA (Drug) $33.73
- Austedo XR (Drug) $26.74
- INVEGA SUSTENNA (Drug) $25.37
- Aristada 441 mg (Drug) $20.09
- HETLIOZ (Drug) $17.52
- Fanapt (Drug) $15.43
- Azstarys (Drug) $15.17
- SUNOSI (Drug) $14.78
- LOREEV XR (Drug) $14.20
- GRALISE (Drug) $14.16
- UZEDY (Drug) $13.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Paul
Dr. Walter Rush, M.d, M.D
Psychiatry — Payments: $94,071
Psychiatry $94,071
Eduardo Trinidad, Md, MD
Psychiatry — Payments: $22,810
Psychiatry $22,810
Gerhardt Wagner, Md, MD
Psychiatry — Payments: $4,960
Psychiatry $4,960
Peter Brodrick, Md, MD
Psychiatry — Payments: $2,073
Psychiatry $2,073
Dr. Mukesh Kumar, Mbbs, MBBS
Psychiatry — Payments: $1,911
Psychiatry $1,911
Robert Schneck, Md, MD
Psychiatry — Payments: $1,462
Psychiatry $1,462